[HTML][HTML] Age and genotype dependent erythropoietin protection in COVID-19
KI Papadopoulos, W Sutheesophon… - World Journal of Stem …, 2021 - ncbi.nlm.nih.gov
Erythropoietin (EPO) is the main mediator of erythropoiesis and an important tissue
protective hormone that appears to mediate an ancestral neuroprotective innate immune …
protective hormone that appears to mediate an ancestral neuroprotective innate immune …
Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells
Y Xiao, L Lai, H Chen, J Shi, FF Zeng, J Li, H Feng… - Molecular …, 2018 - Elsevier
Abstract Interleukin (IL)-33, a member of the IL-1 cytokine family, is highly expressed in
central nervous system (CNS), suggesting its potential role in CNS. Although some studies …
central nervous system (CNS), suggesting its potential role in CNS. Although some studies …
Enhanced Therapeutic Effects of Human Mesenchymal stem Cells Transduced with Secreted Klotho in a Murine Experimental Autoimmune Encephalomyelitis Model
N Maleki, M Rezapour Kalkhoran… - Molecular …, 2024 - Springer
Abstract Treatment of multiple sclerosis (MS) remains a major challenge. The aim of this
study was to evaluate the therapeutic potential of mesenchymal stem cells (MSCs) …
study was to evaluate the therapeutic potential of mesenchymal stem cells (MSCs) …
Intranasal administration of fingolimod (FTY720) attenuates demyelination area in lysolecithin-induced demyelination model of rat optic chiasm
M Ghasemi-Kasman, N Nosratiyan… - Multiple Sclerosis and …, 2022 - Elsevier
Background Fingolimod (FTY720) is an oral immunosuppressive compound that has been
prescribed to multiple sclerosis (MS) patients since 2010. The lipophilicity and low molecular …
prescribed to multiple sclerosis (MS) patients since 2010. The lipophilicity and low molecular …
[PDF][PDF] Ameliorating the effects of Adalimumab on rabbits with experimental cerebral vasospasm after subarachnoid hemorrhage.
G Toğuşlu, MF Erdi, D Araç, F Keskin… - Turkish Journal of …, 2020 - jag.journalagent.com
ABSTRACT BACKGROUND: Adalimumab (ADA), which is a new-generation recombinant
human monoclonal antibody for tumor necrosis factor α (TNFα), has strong anti-inflammatory …
human monoclonal antibody for tumor necrosis factor α (TNFα), has strong anti-inflammatory …